$CORT SEC Filings

Sold 10,000 shares ($1.15M)

Received 413 shares by exercise or conversion ($3.42K) · Sold 413 shares ($47.7K) · Received 24,587 shares by exercise or conversion ($203K) · 1 more

Granted 100,000 Stock Option (right to buy)

Holds 12,191 shares of Common Stock

Received 8,333 shares by exercise or conversion ($180K) · Sold 8,333 shares ($967K)

Received 810 shares by exercise or conversion ($11K) · Sold 810 shares ($93.5K) · Received 9,190 shares by exercise or conversion ($158K) · 1 more

Gave 17,100 shares as a gift · Acquired 10,000 shares (Gift)

REDWOOD CITY, Calif. – September 23, 2026 – Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neu...

Sold 296 shares ($29.8K)

Received 17,493 shares by exercise or conversion ($145K)

Received 10,000 shares by exercise or conversion ($130K) · Sold 10,000 shares ($1.13M)

Sold 10,000 shares ($1.11M)

Received 328 shares as a grant or award

Received 25,000 shares by exercise or conversion ($207K) · Sold 25,000 shares ($2.86M) · Received 300 shares as a grant or award · 1 more

Received 276 shares as a grant or award · Gave up 102 shares to cover exercise price or tax ($11.6K)

Received 328 shares as a grant or award · Gave up 91 shares to cover exercise price or tax ($10.3K)